Home > Boards > US Listed > Medical - Drugs > Horizon Pharma, Inc. (HZNP)

Boy she kicked the bucket after lunch today.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
$Money Bags$ Member Profile
Member Level 
Followed By 109
Posts 14,573
Boards Moderated 2
Alias Born 08/31/06
160x600 placeholder
Data from Uncontrolled Gout Case Series Supports Immunomodulation with KRYSTEXXA® (pegloticase injection) Strategy to Optimi... Business Wire - 11/11/2019 8:00:00 AM
Confidential Treatment Order (ct Order) Edgar (US Regulatory) - 11/8/2019 3:09:01 PM
Confidential Treatment Order (ct Order) Edgar (US Regulatory) - 11/8/2019 3:08:31 PM
Confidential Treatment Order (ct Order) Edgar (US Regulatory) - 11/8/2019 3:07:45 PM
Confidential Treatment Order (ct Order) Edgar (US Regulatory) - 11/8/2019 3:07:10 PM
The Chicago Tribune Names Horizon Therapeutics plc a 2019 Top Workplace Business Wire - 11/8/2019 9:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/7/2019 4:40:06 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/6/2019 7:18:58 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/6/2019 7:08:35 AM
Horizon Therapeutics plc Reports Strong Third-Quarter 2019 Results Business Wire - 11/6/2019 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/5/2019 5:04:57 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 11/5/2019 5:02:43 PM
Horizon Therapeutics plc Brings Gout-Kidney Link into Focus during American Society of Nephrology (ASN) Kidney Week 2019 Business Wire - 11/5/2019 8:00:00 AM
Clinical Study Data Highlighting the Impact of Teprotumumab in Patients With Active Thyroid Eye Disease to Be Presented Durin... Business Wire - 11/4/2019 8:30:00 AM
New Evidence on the Burden of Gout to be Featured in Data Presentations at Upcoming ACR Annual Meeting Business Wire - 11/4/2019 8:00:00 AM
Integrated Clinical Trial Analyses Further Substantiate that Teprotumumab Significantly Improves Debilitating Effects of Thyr... Business Wire - 10/31/2019 10:00:00 AM
Horizon Therapeutics plc Named One of the Most Innovative Companies by Crain’s Chicago Business Business Wire - 10/24/2019 11:15:00 AM
New Combined Data from the Phase 2 & Phase 3 Teprotumumab Clinical Trials to be Presented during the American Thyroid Associa... Business Wire - 10/24/2019 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/17/2019 4:43:24 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/17/2019 4:42:08 PM
FORTUNE & Great Place to Work® Name Horizon Therapeutics plc to Best Small & Medium Workplaces List for Fourth Consecutive Y... Business Wire - 10/17/2019 9:00:00 AM
Horizon Therapeutics plc Initiates PROTECT Trial Evaluating KRYSTEXXA® (pegloticase injection) to Improve Management of Unco... Business Wire - 10/17/2019 8:00:00 AM
New Data from Teprotumumab Phase 3 OPTIC Study Shows Significantly Reduced Double Vision & Improved Quality of Life for Peopl... Business Wire - 10/11/2019 12:30:00 PM
For World Sight Day, Horizon & Prevent Blindness Are Calling on the Thyroid Eye Disease (TED) Community to Put “Vision Firs... Business Wire - 10/10/2019 9:00:00 AM
Horizon Therapeutics plc to Release Third-Quarter 2019 Financial Results and Host Webcast on Nov. 6, 2019 Business Wire - 10/9/2019 8:00:00 AM
$Money Bags$ Member Level  Wednesday, 08/24/16 04:30:54 PM
Re: None
Post # of 678 
Boy she kicked the bucket after lunch today. Timberrrr.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist